Literature DB >> 11420644

3PO, a novel nonviral gene delivery system using engineered Ad5 penton proteins.

L K Medina-Kauwe1, N Kasahara, L Kedes.   

Abstract

This study describes the development of 3PO, a nonviral, protein-based gene delivery vector which utilizes the highly evolved cell-binding, cell-entry and intracellular transport functions of the adenovirus serotype 5 (Ad5) capsid penton protein. A penton fusion protein containing a polylysine sequence was produced by recombinant methods and tested for gene delivery capability. As the protein itself is known to bind integrins through a conserved consensus motif, the penton inherently possesses the ability to bind and enter cells through receptor-mediated internalization. The ability to lyse the cellular endosome encapsulating internalized receptors is also attributed to the penton. The recombinant protein gains the additional function of DNA binding and transport with the appendage of a polylysine motif. This protein retains the ability to form pentamers and mediates delivery of a reporter gene to cultured cells. Interference by oligopeptides bearing the integrin binding motif suggests that delivery is mediated specifically through integrin receptor binding and internalization. The addition of protamine to penton-DNA complexes allows gene delivery in the presence of serum.

Mesh:

Substances:

Year:  2001        PMID: 11420644     DOI: 10.1038/sj.gt.3301448

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  15 in total

1.  Adenovirus dodecahedron allows large multimeric protein transduction in human cells.

Authors:  P Fender; G Schoehn; J Foucaud-Gamen; E Gout; A Garcel; E Drouet; J Chroboczek
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

2.  Specific delivery of corroles to cells via noncovalent conjugates with viral proteins.

Authors:  Hasmik Agadjanian; Jeremy J Weaver; Atif Mahammed; Altan Rentsendorj; Sam Bass; Jihee Kim; Ivan J Dmochowski; Ruth Margalit; Harry B Gray; Zeev Gross; Lali K Medina-Kauwe
Journal:  Pharm Res       Date:  2006-01-19       Impact factor: 4.200

Review 3.  Current status of gene delivery and gene therapy in lacrimal gland using viral vectors.

Authors:  Shivaram Selvam; Padmaja B Thomas; Sarah F Hamm-Alvarez; Joel E Schechter; Douglas Stevenson; Austin K Mircheff; Melvin D Trousdale
Journal:  Adv Drug Deliv Rev       Date:  2006-09-15       Impact factor: 15.470

4.  Chemotherapy targeting by DNA capture in viral protein particles.

Authors:  Hasmik Agadjanian; David Chu; Jae Youn Hwang; Sebastian Wachsmann-Hogiu; Altan Rentsendorj; Lei Song; Vinod Valluripalli; Jay Lubow; Jun Ma; Behrooz Sharifi; Daniel L Farkas; Lali K Medina-Kauwe
Journal:  Nanomedicine (Lond)       Date:  2012-03       Impact factor: 5.307

5.  A mechanistic study of tumor-targeted corrole toxicity.

Authors:  Jae Youn Hwang; Jay Lubow; David Chu; Jun Ma; Hasmik Agadjanian; Jessica Sims; Harry B Gray; Zeev Gross; Daniel L Farkas; Lali K Medina-Kauwe
Journal:  Mol Pharm       Date:  2011-10-25       Impact factor: 4.939

6.  Novel fiber-dependent entry mechanism for adenovirus serotype 5 in lacrimal acini.

Authors:  Jiansong Xie; Lilian Chiang; Janette Contreras; Kaijin Wu; Judy A Garner; Lali Medina-Kauwe; Sarah F Hamm-Alvarez
Journal:  J Virol       Date:  2006-09-20       Impact factor: 5.103

7.  Analysis of targeted viral protein nanoparticles delivered to HER2+ tumors.

Authors:  Jae Youn Hwang; Daniel L Farkas; Lali K Medina-Kauwe
Journal:  J Vis Exp       Date:  2013-06-18       Impact factor: 1.355

8.  Plasmid DNA delivery into MDA-MB-453 cells mediated by recombinant Her-NLS fusion protein.

Authors:  Sivakumar Jeyarajan; Jennifer Xavier; N Madhusudhana Rao; Vijaya Gopal
Journal:  Int J Nanomedicine       Date:  2010-10-05

9.  Photoexcitation of tumor-targeted corroles induces singlet oxygen-mediated augmentation of cytotoxicity.

Authors:  Jae Youn Hwang; David J Lubow; David Chu; Jessica Sims; Felix Alonso-Valenteen; Harry B Gray; Zeev Gross; Daniel L Farkas; Lali K Medina-Kauwe
Journal:  J Control Release       Date:  2012-10-04       Impact factor: 9.776

Review 10.  Development of adenovirus capsid proteins for targeted therapeutic delivery.

Authors:  Lali K Medina-Kauwe
Journal:  Ther Deliv       Date:  2013-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.